Nov-2021
Nov-2021 Tranquil Clinical Research successfully completed a Phase II double blind, placebo controlled COVID trial as the full service CRO conducting all clinical trial operations including Protocol development,...
Feb 2022 – 35% minority enrollment
Tranquil Clinical Research was the only clinical research unit selected to enroll 200 subjects on a device collection trial and successfully enrolled all 200 subjects (achieving 35% minorities)...
We had our annual company conference in magical Disney World.
Tranquil Clinical Research works hard, trains hard and plays hard. We had our annual company conference in magical Disney World.
Tranquil Clinical Research successfully completed a Phase II clinical trial in COVID patients.
Tranquil Clinical Research successfully completed a Phase II clinical trial in COVID patients as the CRO conducting all clinical trial operations including: Protocol development, FDA submissions/approvals, pharmacovigilance, clinical...
Device Trial Rapid Enrollment
Tranquil Clinical Research successfully recruited and enrolled a difficult interventional device trial within two months; where the sponsor's other sites were unable to enroll in 18 months; becoming...
Study of COVID treatment Quellor has first patient at Louisville hospital
Tranquil is proud to announce the success of our strategic research site partner, the cardiology research team at Jewish Hospital in Louisville, KY! Dr. Naresh Solankhi & his...